BLUEJET

Blue Jet Healthcare, a prominent player in the Pharmaceuticals and Biotechnology sector. This positive shift is attributed to a change in the technical grade, indicating a bullish trend in the stock's performance. Currently priced at Rs 899.25, Blue Jet Healthcare has shown impressive resilience, with a 52-week high of Rs 985.60 and a low of Rs 400.05. The stock has generated a remarkable return of 109.76% over the past year, significantly outperforming the BSE500 index, which recorded a return of just 1.74%. The company has demonstrated outstanding financial performance, particularly in Q4 FY24-25, with a net profit growth of 11.23% and a PAT of Rs 110.10 crore, reflecting an impressive 87.6% increase compared to previous quarters. With a market capitalization of Rs 15,599 crore, Blue Jet Healthcare stands as the second-largest company in its sector, accounting for 33.77% of the industry.